Huili Wu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma.
Journal: Oncology research
Published: March 29, 2026
PD-1/PD-L1 expression and predictive value of efficacy in hepatocellular carcinoma patients with anti-PD-1 therapy: a real-world study.
Journal: Journal of gastrointestinal oncology
Published: December 27, 2025
Skeletal muscle index at the third lumbar vertebra/BMI are positively associated with 1-year overall survival in male patients with hepatocellular carcinoma treated with immune checkpoint inhibitors.
Journal: Oncology letters
Published: November 12, 2025
Neoadjuvant Immunochemotherapy Increases the Abundance of Tertiary Lymphoid Structures and Lymphocyte Subpopulations Is Associated With Prognosis of Esophageal Squamous Cell Carcinoma.
Journal: Cancer medicine
Published: November 05, 2025
Immune checkpoint blockade PD-1 therapy for primary liver cancer: incidence and influencing factors of thyroid dysfunction.
Journal: Infectious agents and cancer
Published: July 09, 2022
"Realistic strategies" and neutral processes drive the community assembly based on leaf functional traits in a subtropical evergreen broad-leaved forest.
Journal: Ecology and evolution
Published: June 14, 2022
Comparison of clinical features and liver histology in liver failure caused by autoimmune hepatitis with different prognosis.
Journal: Chinese medical journal
Published: August 27, 2021
The effect of thymopentin add-on in hepatitis B e antigen positive chronic hepatitis B after virus suppression by peginterferon plus entecavir therapy.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: December 18, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026